The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Identification of outcome-correlated serum cytokine and chemokine clusters in ovarian clear cell carcinoma.
 
Akira Yabuno
No Relationships to Disclose
 
Hirokazu Matsushita
No Relationships to Disclose
 
Daisuke Shintani
No Relationships to Disclose
 
Tetsutaro Hamano
No Relationships to Disclose
 
Nao Fujieda
No Relationships to Disclose
 
Sho Sato
No Relationships to Disclose
 
Tadaaki Nishikawa
No Relationships to Disclose
 
Keiichi Fujiwara
Honoraria - Bayer; Chugai Pharma; Daiichi Sankyo; Eisai; Janssen Oncology; Kyowa Hakko Kirin; Lilly Japan; Nippon Kayaku; Ono Pharmaceutical; Taiho Pharmaceutical; Zeria Pharmaceutical
Consulting or Advisory Role - AstraZeneca; Chugai Pharma; Eisai; MSD; Pfizer; Taiho Pharmaceutical; Takeda
Research Funding - AstraZeneca (Inst); Chugai Pharma (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Immunogen (Inst); Kaken Pharmaceutical (Inst); Lilly (Inst); MSD (Inst); Oncotherapeutics (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst); Zeria Pharmaceutical (Inst)
 
Kazuhiro Kakimi
No Relationships to Disclose
 
Kosei Hasegawa
Honoraria - Chugai Pharma; Daiichi Sankyo; Ono Pharmaceutical
Consulting or Advisory Role - Daiichi Sankyo; MSD
Research Funding - OncoTherapy Science (Inst); Pfizer (Inst); Yakult Pharmaceutical (Inst)